Source: PMLiVE

ARMO BioSciences: Lilly adds AurKa Pharma to oncology buying spree

Lilly is buying back its former drug after just two years

Read full article »
ARMO BioSciences's Competitors | ARMO BioSciences's News | ARMO BioSciences's Financials
Stay up-to-date with the latest news on ARMO BioSciences
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Peter Van Vlasselaer's photo - President & CEO of ARMO BioSciences

President & CEO

Peter Van Vlasselaer

CEO Approval Rating

93/100

Read more
Stay up-to-date with the latest news on ARMO BioSciences